Compare WEN & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WEN | PRGO |
|---|---|---|
| Founded | 1969 | 1887 |
| Country | United States | Ireland |
| Employees | 14500 | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | N/A | 1991 |
| Metric | WEN | PRGO |
|---|---|---|
| Price | $8.37 | $13.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 21 | 4 |
| Target Price | $10.42 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 7.1M | 3.6M |
| Earning Date | 11-07-2025 | 11-05-2025 |
| Dividend Yield | 6.63% | ★ 8.71% |
| EPS Growth | ★ 0.63 | N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | $2,208,190,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.06 | N/A |
| P/E Ratio | $8.93 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.83 | $12.17 |
| 52 Week High | $17.20 | $30.93 |
| Indicator | WEN | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 48.51 | 38.12 |
| Support Level | $8.14 | $12.74 |
| Resistance Level | $8.61 | $13.63 |
| Average True Range (ATR) | 0.31 | 0.43 |
| MACD | 0.03 | 0.24 |
| Stochastic Oscillator | 50.98 | 38.27 |
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $12.6 billion in 2024, narrowly edging Burger King ($11.5 billion) and clocking in well behind wide-moat McDonald's ($51.1 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spanned more than 7,200 total stores in 30 countries as of year-end 2024. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for roughly 94% of stores, and through franchise flipping and advisory fees.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.